SureTrader SureTrader
Home > Boards > Canadian > Biotechs >

Breathtec Biomedical Inc. (BTHCF)

Add BTHCF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, GOLD DIGGAA, SO75
Search This Board:
Last Post: 10/20/2016 6:37:56 PM - Followers: 19 - Board type: Free - Posts Today: 0

Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Our primary avenue of investigation is focused on innovation and advances in the field of specialized mass spectrometry.

The principal market opportunity arises from the potential of low-cost, non-intrusive diagnostic screening in general medical practice which could lead to notable advances in early detection of major cancers and other life-altering diseases.

Regular screening using a simple breath test, could lead to significant advancements in remedial treatment protocols targeting major improvements in survivability and life quality.

Corporate Presentation

Company filings


Michael T. Costanzo, Ph.D., Chief Executive Officer

Dr. Costanzo enjoys a passion for science that has directed his career path firmly into the field of analytical chemistry. Over the past five years he has investigated a variety of advanced experimental methodologies and instrumentation with the Yost Research Group at the University of Florida. During this period he utilized UV spectroscopy to help in standardizing procedures for manufacturing respiratory medications, employed novel ion mobility spectrometric techniques and devices to analyze exhaled breath, and performed multiple metabolomics studies of melanoma. Through his efforts, he acquired a vast knowledge of analytical techniques and methodologies and an immense desire for scientific progress.

Previously, Costanzo obtained his Bachelor of Science in chemistry at the State University of New York (Buffalo). During this period he conducted research under Dr. Troy Wood utilizing mass spectrometry to examine products of enzymatic protein digestion in the interest of studying metabolic markers of autism in children. Upon graduation in 2010 he moved to the University of Florida for Ph.D. studies and as a result of his efforts has recently joined with Breathtec Biomedical to propel his own bioanalytical research through the development of revolutionary clinical devices utilizing his background in ion mobility, mass spectrometry, and exhaled breath analysis.


Kal Malhi, President and Director

Mr. Malhi is a Canadian entrepreneur and businessman. He is a retired member of the Royal Canadian Mounted Police and also President of BullRun Group, a private investment company specializing in early stage business development.

His interest in issues of individual rights aligned with public safety through law enforcement initiatives shaped his vision in the founding of Cannabix Breathalyzer, Inc where Mr. Malhi was instrumental in growing the company from a startup to a publicly traded company with a valuation in excess of $30 million dollars.

This successful enterprise broadened his interest in breath analysis and the extraordinary opportunities in the sector. His extensive network of contacts and personal relationships has enabled him to assemble a growing team aimed at unearthing the potential for commercial breath analysis applications as a new and potentially high growth sector


Raj Attariwala, MD, PhD., Lead Engineer

Dr. Attariwala is a dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).

Dr. Attariwala is a practicing physician in British Columbia and owner of AIM medical imaging. He has pioneered advances in the field of whole body medical imaging and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection.

Dr. Attariwala has extensively investigated breath testing applications and efficacy in a related role at Cannabix Technologies Inc. where he developed a breath testing system for drug impairment.


Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Dr. Yost’s research has involved over 100 graduate students funded by over $40 million in research grants, and has published over 160 papers and 16 patents. Over $30 billion worth of instruments have been sold based on these patents.

He serves as a member of the Florida Board of Governors (Regents) and as the Chair of the Advisory Council of Faculty Senates of Florida. He is past Chair of the UF Faculty Senate and served on the UF Board of Trustees. He served as Treasurer and Secretary of the American Society for Mass Spectrometry, and on the editorial boards of The Journal of the American Society for Mass Spectrometry and The International Journal of Mass Spectrometry.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#241  Sticky Note Breathtec BioMedical Announces Private Placement DiamondInTheRough 10/19/16 08:59:49 AM
#151  Sticky Note DEVICE TO BE DEMOED ON JUNE 29 GOLD DIGGAA 06/21/16 05:05:00 PM
#254   Breathtec has moved beyond the ^ June Sticky AMG 10/20/16 06:37:56 PM
#253   "This device will be a game changer for ILuvblo2 10/20/16 04:59:32 PM
#252   With regards to your question of what they DiamondInTheRough 10/19/16 05:04:35 PM
#251   I'll be watching this one. Looking for 13 SO75 10/19/16 02:58:39 PM
#250   ...or we simply will experience and delayed response DiamondInTheRough 10/19/16 02:44:33 PM
#249   Hello and welcome. DiamondInTheRough 10/19/16 11:55:45 AM
#248   hallo to all! hoyowasobo 10/19/16 11:30:42 AM
#247   Overall it's good news...Presuming they have an easy AMG 10/19/16 10:54:00 AM
#246   I see no fault in that assumption. DiamondInTheRough 10/19/16 10:52:05 AM
#245   The 0.075 shares and the 0.15 warrants 2 shares SO75 10/19/16 10:44:04 AM
#244   I'm holding what I purchased yesterday and will DiamondInTheRough 10/19/16 10:42:35 AM
#243   It is definitely why the recent run has DiamondInTheRough 10/19/16 10:40:35 AM
#242   This may be why it dropped SO75 10/19/16 10:25:07 AM
#241   Breathtec BioMedical Announces Private Placement DiamondInTheRough 10/19/16 08:59:49 AM
#240   I transferred over large majority of my remaining DiamondInTheRough 10/18/16 04:53:08 PM
#239   BTHCF Great recovery off of the recent bottom! Dadx4 10/18/16 04:36:34 PM
#238   Word of advice...Pull The Trigger. The only thing AMG 10/18/16 04:29:33 PM
#237   Breathalyzer markets at $284.6 million in 2011 are SO75 10/18/16 03:54:38 PM
#236   Been watching action here from sideline today, big DiamondInTheRough 10/18/16 02:38:13 PM
#235   I haven't placed a single $ here yet DiamondInTheRough 10/18/16 11:31:53 AM
#234   BTHCF---GLTA! Dadx4 10/17/16 03:23:45 PM
#233   October 17, 2016 SO75 10/17/16 09:25:46 AM
#232   Something (sudden) triggered the sell off. SO75 10/13/16 04:08:03 PM
#231   not the reason here imo. it uses blood mirahira 10/13/16 02:29:01 PM
#230   This may be the kicker right here. SO75 10/13/16 01:21:47 PM
#229   Shell SO75 10/13/16 09:55:36 AM
#226   this stock has tough competition imo. maybe some mirahira 10/12/16 09:44:50 AM
#225   quote? mirahira 10/12/16 09:34:09 AM
#222   Trial testing in Surrey starting in October.. I ILuvblo2 10/12/16 07:51:23 AM
#221   yea ready to go for: mirahira 10/12/16 05:43:24 AM
#220   blozf will end up like bthcf mirahira 10/12/16 05:36:28 AM
#218   Volumes ticking up.. trial testing started in October. ILuvblo2 10/11/16 09:54:48 PM
#217   This thing is ready to go!!!! Trial testing ILuvblo2 10/11/16 12:13:36 PM
#216   Now let us go visit BLOZF share price shell3 10/10/16 01:50:36 PM
#215   I believe that was a good $32,000 spent shell3 10/10/16 01:49:25 PM
#213   don't bet money you can't afford to lose geodcan 10/09/16 03:57:53 PM
#212   I'm loaded up on blo I'm just wanting to SO75 10/09/16 03:35:15 PM
#211   cut your losses and buy blozf if you geodcan 10/09/16 03:33:54 PM
#209   The future of finding disease's - Trials shell3 10/08/16 01:26:21 PM
#208   Per the filing on the 6th - FAIMS shell3 10/08/16 01:20:29 PM
#207   The quote is the Monthly filing or do shell3 10/08/16 11:20:55 AM
#206   These shares dropped from 30 to 11 in SO75 10/08/16 09:50:15 AM
#204   I agree someone is doing this before the shell3 10/08/16 05:55:08 AM
#203   Testing starting in October. This is someone ILuvblo2 10/07/16 03:34:13 PM
#201   i rather think they are having massive problems mirahira 10/07/16 01:06:30 PM
#200   What happened over here? Everyone dump this to Mr Bylo 10/07/16 11:47:07 AM
#199   This is extremely concerning SO75 10/07/16 10:37:10 AM
#198   BITHCF Slapped. willlbone 10/07/16 10:04:33 AM
#196   red day again with low volume? mirahira 10/07/16 08:09:09 AM
#195   the support level of this stock will be mirahira 10/07/16 08:08:47 AM